GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cryomass Technologies Inc (OTCPK:CRYM) » Definitions » Shares Outstanding (EOP)

Cryomass Technologies (Cryomass Technologies) Shares Outstanding (EOP) : 210.03 Mil (As of Sep. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Cryomass Technologies Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Cryomass Technologies's shares outstanding for the quarter that ended in Sep. 2023 was 210.03 Mil.

Cryomass Technologies's quarterly shares outstanding increased from Jun. 2023 (205.77 Mil) to Sep. 2023 (210.03 Mil). It means Cryomass Technologies issued new shares from Jun. 2023 to Sep. 2023 .

Cryomass Technologies's annual shares outstanding increased from Dec. 2021 (196.95 Mil) to Dec. 2022 (202.65 Mil). It means Cryomass Technologies issued new shares from Dec. 2021 to Dec. 2022 .


Cryomass Technologies Shares Outstanding (EOP) Historical Data

The historical data trend for Cryomass Technologies's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryomass Technologies Shares Outstanding (EOP) Chart

Cryomass Technologies Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.40 106.22 97.01 196.95 202.65

Cryomass Technologies Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 202.53 202.65 204.78 205.77 210.03

Competitive Comparison of Cryomass Technologies's Shares Outstanding (EOP)

For the Drug Manufacturers - Specialty & Generic subindustry, Cryomass Technologies's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryomass Technologies's Shares Outstanding (EOP) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cryomass Technologies's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Cryomass Technologies's Shares Outstanding (EOP) falls into.



Cryomass Technologies Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Cryomass Technologies  (OTCPK:CRYM) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Cryomass Technologies Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Cryomass Technologies's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryomass Technologies (Cryomass Technologies) Business Description

Traded in Other Exchanges
N/A
Address
1001 Bannock Street, Suite 612, Denver, CO, USA, 80204
Cryomass Technologies Inc designs, manufactures, and licenses field-mobile equipment for the handling of harvested cannabis, hemp, and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect and protect the high-value compounds from the harvested plant. The company's offerings include refinement systems and monitoring and control systems.
Executives
Philip Blair Mullin officer: Chief Financial Officer 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Christian Noel director, officer: Chief Executive Officer 3531 SOUTH LOGAN ST. SUITE D-357, ENGLEWOOD CO 80113
Patricia Izabel Kovacevic officer: GC, Corp Secy, and Head of EA 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Delon Hannes Human director 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mark Radke director 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mario Gobbo director 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113